Cited 0 times in Scipus Cited Count

Prognostic Significance of Lymphocyte Counts in Colon Cancer Patients Treated with FOLFOX Chemotherapy

DC Field Value Language
dc.contributor.authorNoh, OK-
dc.contributor.authorOh, SY-
dc.contributor.authorKim, YB-
dc.contributor.authorSuh, KW-
dc.date.accessioned2018-08-24T01:48:22Z-
dc.date.available2018-08-24T01:48:22Z-
dc.date.issued2017-
dc.identifier.issn0364-2313-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/15833-
dc.description.abstractPURPOSE: There is increasing interest in immune function in combination with chemotherapy for cancer treatment. However, the effects of chemotherapy on the human immune system remain to be determined. The aim of this study was to investigate the prognostic impact of lymphocyte and neutrophil counts in colon cancer patients who were treated with curative surgery and adjuvant chemotherapy.
METHODS: Two hundred thirty-one patients with colon cancers who underwent curative surgery and FOLFOX adjuvant chemotherapy between November 2005 and December 2011 were included. Oncologic outcomes were analyzed with neutrophil count, lymphocyte count, and neutrophil-to-lymphocyte ratio (NLR) before and after chemotherapy.
RESULTS: The 5-year DFS rate was lower in colon cancer patients with low lymphocyte count during chemotherapy (61.9 vs. 76.7%, P = 0.026). Cox multivariate analysis demonstrated that low lymphocyte count during chemotherapy was independently associated with poor disease-free survival (HR 1.829: 95% CI 1.096-3.050: P = 0.021) in colon cancer patients who underwent FOLFOX adjuvant chemotherapy.
CONCLUSION: Lymphocyte count during chemotherapy is a strong predictor of worse disease-free survival in colon cancer patients who have undergone FOLFOX adjuvant chemotherapy.
-
dc.language.isoen-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAntineoplastic Combined Chemotherapy Protocols-
dc.subject.MESHChemotherapy, Adjuvant-
dc.subject.MESHColonic Neoplasms-
dc.subject.MESHDisease-Free Survival-
dc.subject.MESHFemale-
dc.subject.MESHFluorouracil-
dc.subject.MESHHumans-
dc.subject.MESHLeucovorin-
dc.subject.MESHLymphocyte Count-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHMultivariate Analysis-
dc.subject.MESHNeutrophils-
dc.subject.MESHOrganoplatinum Compounds-
dc.subject.MESHPrognosis-
dc.subject.MESHYoung Adult-
dc.titlePrognostic Significance of Lymphocyte Counts in Colon Cancer Patients Treated with FOLFOX Chemotherapy-
dc.typeArticle-
dc.identifier.pmid28707088-
dc.contributor.affiliatedAuthor노, 오규-
dc.contributor.affiliatedAuthor오, 승엽-
dc.contributor.affiliatedAuthor김, 영배-
dc.contributor.affiliatedAuthor서, 광욱-
dc.type.localJournal Papers-
dc.identifier.doi10.1007/s00268-017-4104-6-
dc.citation.titleWorld journal of surgery-
dc.citation.volume41-
dc.citation.number11-
dc.citation.date2017-
dc.citation.startPage2898-
dc.citation.endPage2905-
dc.identifier.bibliographicCitationWorld journal of surgery, 41(11). : 2898-2905, 2017-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1432-2323-
dc.relation.journalidJ003642313-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Radiation Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse